|
1
|
Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
|
Infect Immun
|
2003
|
1.06
|
|
2
|
Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
|
Mol Pharmacol
|
2006
|
1.01
|
|
3
|
Stereoselectivity toward VX is determined by interactions with residues of the acyl pocket as well as of the peripheral anionic site of AChE.
|
Biochemistry
|
2004
|
0.83
|
|
4
|
Controlled concealment of exposed clearance and immunogenic domains by site-specific polyethylene glycol attachment to acetylcholinesterase hypolysine mutants.
|
J Biol Chem
|
2007
|
0.83
|
|
5
|
Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
|
Mol Pharmacol
|
2008
|
0.82
|
|
6
|
Functional requirements for the optimal catalytic configuration of the AChE active center.
|
Chem Biol Interact
|
2005
|
0.81
|
|
7
|
Amino acid domains control the circulatory residence time of primate acetylcholinesterases in rhesus macaques (Macaca mulatta).
|
Biochem J
|
2004
|
0.79
|
|
8
|
Overloading and removal of N-glycosylation targets on human acetylcholinesterase: effects on glycan composition and circulatory residence time.
|
Biochem J
|
2002
|
0.78
|
|
9
|
The role of AChE active site gorge in determining stereoselectivity of charged and noncharged VX enantiomers.
|
Chem Biol Interact
|
2005
|
0.78
|
|
10
|
Is aromaticity essential for trapping the catalytic histidine 447 in human acetylcholinesterase?
|
Biochemistry
|
2004
|
0.77
|
|
11
|
Lessons from functional analysis of AChE covalent and noncovalent inhibitors for design of AD therapeutic agents.
|
Chem Biol Interact
|
2005
|
0.76
|
|
12
|
Flexibility versus "rigidity" of the functional architecture of AChE active center.
|
Chem Biol Interact
|
2008
|
0.75
|